AGL188W Antibody

What is AGL188W Antibody and what organism does it target?

AGL188W Antibody (Product Code: CSB-PA744954XA01DOT) is a polyclonal antibody specifically raised against the AGL188W protein from Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056), also known as Eremothecium gossypii. This filamentous fungal species serves as an important model organism in molecular biology research. The antibody recognizes the naturally occurring AGL188W protein expressed in this yeast strain, making it valuable for studies focusing on Ashbya gossypii protein expression and function .

What are the physical and biochemical properties of AGL188W Antibody?

The AGL188W Antibody is supplied in liquid form with clearly defined biochemical properties:

This polyclonal antibody is non-conjugated and purified using antigen affinity chromatography to ensure specific binding to the target protein .

What applications has AGL188W Antibody been validated for?

AGL188W Antibody has been validated for specific laboratory applications essential for research:

These applications enable quantitative (ELISA) and qualitative (Western Blot) detection of the AGL188W protein in experimental samples. When designing experiments, researchers should ensure proper protocol optimization for each application to maximize specificity and sensitivity .

How should optimal working dilutions be determined for AGL188W Antibody in Western blot applications?

Determining optimal working dilutions for AGL188W Antibody requires systematic titration experiments. Begin with a recommended starting dilution range of 1:500 to 1:2000 for Western blot applications. Prepare a dilution series (e.g., 1:500, 1:1000, 1:2000, 1:5000) and run identical protein samples to identify the concentration that provides optimal signal-to-noise ratio.

When optimizing, consider these methodological factors:

• Use both positive controls (A. gossypii extracts) and negative controls (unrelated yeast extracts)

• Implement a step-gradient blocking protocol (3-5% non-fat dry milk or BSA)

• Test different exposure times to identify the optimal signal window

• Document band intensity using densitometric analysis to quantify optimal working concentration

The dilution providing clear specific bands with minimal background should be selected for subsequent experiments, followed by consistent application across studies to ensure reproducibility .

What are the recommended sample preparation protocols for detecting AGL188W protein in Ashbya gossypii?

For optimal detection of AGL188W protein from Ashbya gossypii samples, follow this methodological workflow:

• Culture Harvesting: Collect cells during logarithmic growth phase (OD600 1.0-1.5) for maximum protein yield

• Cell Disruption: Use either mechanical disruption (glass beads) or enzymatic lysis (zymolyase treatment) followed by gentle sonication

• Protein Extraction Buffer:

  • 50 mM Tris-HCl (pH 7.5)

  • 150 mM NaCl

  • 1% Triton X-100

  • 1 mM EDTA

  • Protease inhibitor cocktail (freshly added)

• Sample Processing: Centrifuge lysates at 12,000×g for 20 minutes at 4°C

• Protein Quantification: Use Bradford or BCA assay to normalize loading

• Sample Preparation: Mix with 4× Laemmli buffer (with reducing agent) and heat at 95°C for 5 minutes

This protocol maintains protein integrity while maximizing extraction efficiency of the target protein. For challenging samples, consider incorporating a pre-clearing step using Protein A/G beads to reduce non-specific binding .

Can AGL188W Antibody be used for immunoprecipitation experiments?

While AGL188W Antibody has not been specifically validated for immunoprecipitation (IP), polyclonal antibodies purified by antigen affinity like this one can often be adapted for IP applications. When designing an IP experiment with AGL188W Antibody, researchers should:

• Begin with a higher antibody concentration than used for Western blotting (typically 2-5 μg per reaction)

• Pre-clear lysates with Protein A agarose beads (appropriate for rabbit IgG) for 1 hour at 4°C

• Incubate pre-cleared lysates with AGL188W Antibody overnight at 4°C with gentle rotation

• Capture antibody-antigen complexes with fresh Protein A beads for 2-4 hours

• Perform extensive washing (at least 5 times) with decreasing salt concentrations

• Validate results with appropriate controls, including:

  • IgG control from non-immunized rabbits

  • Lysates from organisms not expressing AGL188W protein

Because this application requires optimization beyond the vendor-validated uses, thorough validation through Western blot analysis of immunoprecipitated proteins is essential to confirm specificity and efficiency .

How does AGL188W Antibody compare with other antibodies targeting yeast proteins in terms of cross-reactivity?

Comparative cross-reactivity analysis with related yeast species:

To experimentally determine cross-reactivity:

• Perform Western blot analysis using protein extracts from multiple yeast species

• Include gradient protein concentrations to assess sensitivity differences

• Document band patterns and molecular weights to identify potential cross-reacting proteins

• Consider epitope mapping to identify shared antigenic determinants

This systematic approach provides crucial information about antibody specificity that directly impacts experimental design and interpretation in comparative fungal studies .

What strategies can be employed to optimize AGL188W Antibody performance in challenging experimental conditions?

Optimizing AGL188W Antibody performance under challenging conditions requires systematic methodology adjustments:

• For Low Abundance Protein Detection:

  • Implement signal amplification systems (e.g., biotin-streptavidin)

  • Increase protein loading (up to 100 μg per lane)

  • Extend primary antibody incubation to overnight at 4°C

  • Use high-sensitivity chemiluminescent substrates

• For High Background Reduction:

  • Implement gradient blocking optimization (3%, 5%, and 10% BSA or milk)

  • Add 0.1-0.3% Tween-20 to washing buffers

  • Perform pre-adsorption of antibody with unrelated yeast lysates

  • Increase washing duration and frequency (6-8 washes of 10 minutes each)

• For Samples with Interfering Compounds:

  • Incorporate TCA precipitation to eliminate interfering substances

  • Use specialized extraction buffers containing chaotropic agents

  • Implement dialysis or size-exclusion chromatography for sample cleanup

• For Degradation-Prone Samples:

  • Increase protease inhibitor concentration (2-3× standard)

  • Maintain samples at 4°C throughout processing

  • Add phosphatase inhibitors if phosphorylation status is relevant

  • Consider using freshly prepared reagents for all steps

These methodological adaptations should be systematically tested and documented to establish optimal conditions for specific experimental scenarios .

How can AGL188W Antibody be used in comparative studies between wild-type and mutant Ashbya gossypii strains?

AGL188W Antibody offers powerful applications for comparing protein expression between wild-type and mutant A. gossypii strains. For rigorous comparative studies, implement this methodological framework:

• Experimental Design Considerations:

  • Match growth conditions precisely between strains

  • Harvest cells at identical growth phases (monitor by OD600)

  • Process all samples simultaneously to minimize technical variation

  • Include biological replicates (n≥3) for statistical validity

• Quantitative Western Blot Protocol:

  • Normalize protein loading using total protein normalization (rather than single housekeeping proteins)

  • Implement technical triplicates at minimum

  • Include standard curves using recombinant AGL188W protein

  • Analyze using digital image quantification software with statistical validation

• Complementary Approaches:

  • Couple Western blot results with transcript analysis (RT-qPCR)

  • Consider subcellular fractionation to assess protein localization differences

  • Implement pulse-chase experiments to evaluate protein turnover rates

• Data Interpretation Framework:

  • Apply appropriate statistical tests (e.g., t-test, ANOVA)

  • Normalize expression to multiple reference points

  • Document all experimental variables that could influence protein expression

This integrated approach provides robust comparative data between wild-type and mutant strains, offering insights into AGL188W protein regulation and function in different genetic backgrounds .

What are common troubleshooting strategies when AGL188W Antibody produces unexpected results?

When encountering unexpected results with AGL188W Antibody, implement this systematic troubleshooting approach:

Additionally, consider implementing validation experiments such as:

• Peptide competition assays to confirm specificity

• Knockout/knockdown controls to verify target authenticity

• Secondary antibody-only controls to identify non-specific binding

• Cross-platform validation (e.g., combining Western blot with mass spectrometry)

This systematic approach helps identify the source of problematic results and guides appropriate experimental adjustments .

How can researchers validate AGL188W Antibody specificity in new experimental systems?

Validating AGL188W Antibody specificity in new experimental systems requires implementing multiple orthogonal approaches:

• Epitope Competition Assay:

  • Pre-incubate antibody with excess recombinant AGL188W protein

  • Compare signal between competed and non-competed antibody

  • Specific binding should show significant signal reduction after competition

• Genetic Validation:

  • Generate AGL188W knockout or knockdown strains

  • Compare antibody reactivity between wild-type and modified strains

  • Specific antibodies will show diminished or absent signal in knockout/knockdown samples

• Mass Spectrometry Validation:

  • Perform immunoprecipitation with AGL188W Antibody

  • Analyze precipitated proteins using mass spectrometry

  • Confirm presence of AGL188W protein and document any co-precipitating proteins

• Orthogonal Detection Methods:

  • Express tagged versions of AGL188W protein (e.g., FLAG, His)

  • Perform parallel detection with both AGL188W Antibody and tag-specific antibodies

  • Compare detection patterns to confirm target identity

• Cross-Laboratory Validation:

  • Coordinate with collaborating laboratories using different equipment/reagents

  • Implement standardized protocols across sites

  • Compare results to identify and eliminate lab-specific artifacts

This multi-faceted validation approach provides robust evidence of antibody specificity that meets publication standards and ensures experimental reproducibility .

What controls should be included when using AGL188W Antibody for the first time in a laboratory?

When introducing AGL188W Antibody into a new laboratory setting, incorporate these essential controls to establish reliability and specificity:

• Sample-Related Controls:

  • Positive control: Verified A. gossypii extract with documented AGL188W expression

  • Negative control: Non-target yeast extract (e.g., S. cerevisiae)

  • Gradient controls: Serial dilutions of positive control to establish detection limits

• Antibody-Related Controls:

  • Isotype control: Non-specific rabbit IgG at matching concentration

  • Secondary-only control: Omit primary antibody to identify non-specific binding

  • Antibody titration: Multiple dilutions to identify optimal working concentration

• Technical Controls:

  • Loading control: Total protein stain (e.g., Ponceau S) or housekeeping protein detection

  • Protocol validation: Side-by-side comparison with established antibody protocols

  • Replicate analysis: Technical triplicates to establish reproducibility

• Advanced Validation Controls:

  • Pre-absorption control: Pre-incubate antibody with recombinant AGL188W protein

  • Multi-lot testing: Compare performance across different antibody lots if available

  • Cross-platform validation: Compare results between different detection methods

Systematic implementation of these controls not only validates AGL188W Antibody performance but also establishes a foundation for troubleshooting should problems arise in future experiments .

How can AGL188W Antibody be incorporated into advanced imaging techniques for studying Ashbya gossypii biology?

AGL188W Antibody can be adapted for advanced imaging applications through systematic protocol development:

• Immunofluorescence Microscopy Protocol:

  • Fix Ashbya gossypii cells with 4% paraformaldehyde followed by partial cell wall digestion

  • Permeabilize with 0.1% Triton X-100 for intracellular access

  • Block with 3% BSA supplemented with 0.1% Tween-20

  • Apply AGL188W Antibody at 1:100-1:500 dilution (requires optimization)

  • Detect using fluorophore-conjugated anti-rabbit secondary antibodies

  • Include DAPI staining for nuclear visualization

• Super-Resolution Microscopy Adaptations:

  • For STORM/PALM: Use photoswitchable fluorophore-labeled secondary antibodies

  • For SIM/STED: Optimize fixation to minimize autofluorescence

  • Implement drift correction markers for extended imaging sessions

  • Consider dual-color imaging with cytoskeletal markers for spatial context

• Correlative Light and Electron Microscopy (CLEM):

  • Develop gold-conjugated secondary antibody protocols

  • Optimize osmium staining compatibility

  • Establish registration markers for correlative imaging

  • Validate ultrastructural preservation during immunolabeling

• Live-Cell Adaptations:

  • Consider developing cell-permeable Fab fragments from AGL188W Antibody

  • Optimize minimal labeling concentrations to reduce perturbation

  • Implement photobleaching controls to distinguish specific from non-specific signals

These advanced imaging applications extend AGL188W Antibody utility beyond biochemical detection into spatial biology investigations of Ashbya gossypii .

What are potential applications of AGL188W Antibody in multi-omics research approaches?

AGL188W Antibody offers valuable integration points across multi-omics research platforms:

• Immuno-Proteomics Applications:

  • Immunoprecipitation coupled with mass spectrometry (IP-MS) to identify interaction partners

  • ChIP-MS (Chromatin Immunoprecipitation-Mass Spectrometry) if AGL188W has DNA-binding properties

  • Proximity labeling approaches (BioID or APEX) using AGL188W as bait protein

  • Absolute protein quantification using AGL188W Antibody as a capture reagent

• Integration with Transcriptomics:

  • Correlative analysis between protein levels (detected by AGL188W Antibody) and transcript abundance

  • Validation of transcriptional regulation models through protein expression confirmation

  • Assessment of post-transcriptional regulation through protein/mRNA ratio analysis

  • Ribosome profiling coupled with Western blot validation

• Functional Genomics Applications:

  • Phenotypic screening following genetic perturbation with AGL188W protein detection

  • CRISPR-Cas9 editing validation at protein level

  • Genetic interaction mapping with protein-level readouts

  • Synthetic genetic array (SGA) analysis with immunodetection validation

• Systems Biology Integration:

  • Pathway modeling validation using quantitative Western blot data

  • Temporal profiling of AGL188W protein during cell cycle progression

  • Mathematical modeling of protein turnover rates

  • Network analysis validation through co-immunoprecipitation experiments

This multi-omics integration maximizes the research value of AGL188W Antibody beyond single-technique applications, enabling comprehensive understanding of AGL188W protein function in cellular contexts .

How might AGL188W Antibody contribute to understanding evolutionary conservation of fungal proteins?

AGL188W Antibody can serve as a powerful tool for investigating evolutionary conservation across fungal species through these methodological approaches:

• Comparative Immunoblotting Strategy:

  • Collect protein extracts from phylogenetically diverse fungi (e.g., Saccharomyces, Candida, Aspergillus)

  • Normalize protein loading using conserved housekeeping proteins

  • Probe with AGL188W Antibody to detect cross-reactive proteins

  • Document molecular weight variations and expression levels

  • Correlate immunoreactivity with phylogenetic distance from A. gossypii

• Epitope Mapping Approach:

  • Generate peptide arrays covering predicted AGL188W homologs

  • Probe arrays with AGL188W Antibody to identify conserved epitopes

  • Cross-reference reactive epitopes with sequence conservation analysis

  • Identify functional domains that show highest conservation

• Structural Biology Integration:

  • Combine immunoreactivity data with protein structure predictions

  • Map conserved epitopes onto 3D structural models

  • Identify surface-exposed versus buried conserved regions

  • Correlate antibody binding with predicted functional domains

• Evolutionary Rate Analysis:

  • Measure selective pressure on antibody-binding regions

  • Compare rates of epitope evolution across fungal lineages

  • Correlate antibody reactivity with calculated Ka/Ks ratios

  • Document relationship between functional constraints and epitope conservation

These approaches leverage AGL188W Antibody as a molecular probe for evolutionary studies, providing insights into protein conservation patterns that complement sequence-based phylogenetic analyses .

How might AGL188W Antibody be adapted for high-throughput screening applications in fungal research?

Adapting AGL188W Antibody for high-throughput screening requires systematic protocol miniaturization and automation:

• Microplate-Based ELISA Development:

  • Optimize coating conditions for fungal lysates in 384-well format

  • Develop automated washing protocols that maintain sensitivity

  • Establish signal normalization methods for plate-to-plate consistency

  • Validate Z-factor scores >0.5 to confirm assay robustness

  • Implement machine learning algorithms for automated result interpretation

• Automated Western Blot Adaptation:

  • Develop capillary-based Western protocols compatible with AGL188W Antibody

  • Optimize protein extraction methods for microplate format

  • Establish minimum detectable concentration thresholds

  • Validate across multiple fungal strains and growth conditions

• High-Content Imaging Applications:

  • Develop immunofluorescence protocols in 96/384-well formats

  • Optimize fixation and permeabilization for automated liquid handling

  • Establish automated image acquisition and analysis workflows

  • Implement nuclear counterstaining for cell segmentation algorithms

  • Validate phenotypic readouts through correlation with biochemical assays

• Bead-Based Multiplex Detection:

  • Conjugate AGL188W Antibody to distinguishable microbeads

  • Develop multiplexed assays with other fungal protein markers

  • Optimize sample preparation for flow cytometry-based detection

  • Validate dynamic range and coefficient of variation across batches

These high-throughput adaptations would enable large-scale screening of genetic libraries, environmental isolates, or drug compounds affecting AGL188W protein expression or function .

What are potential applications of AGL188W Antibody in studying fungal pathogen-host interactions?

While Ashbya gossypii is not typically pathogenic, AGL188W Antibody methodology can be adapted to study conserved fungal proteins in host-pathogen contexts:

• Cross-Species Application Assessment:

  • Evaluate AGL188W sequence homology with proteins from pathogenic fungi

  • Test cross-reactivity with extracts from Candida, Aspergillus, and Cryptococcus species

  • Identify conserved epitopes with potential functional significance

  • Establish detection limits in mixed host-pathogen samples

• Host Response Characterization:

  • Develop co-culture systems with immune cells and fungal species

  • Use AGL188W Antibody to track fungal protein expression during host interaction

  • Correlate protein expression changes with virulence phenotypes

  • Monitor temporal dynamics of protein expression during infection progression

• Therapeutic Target Validation:

  • Employ AGL188W Antibody to validate target engagement of antifungal compounds

  • Develop competitive binding assays for drug screening

  • Monitor protein level changes following drug treatment

  • Correlate protein expression with survival in infection models

• Fungal Adaptation Monitoring:

  • Track protein expression changes in response to host environment stressors

  • Develop quantitative assays for protein expression under varying host conditions

  • Correlate expression patterns with transcriptional responses

  • Identify post-translational modifications induced by host defense mechanisms

These applications would extend AGL188W Antibody utility beyond basic research into potential translational applications in medical mycology and infectious disease research .

How can researchers contribute to improving AGL188W Antibody validation standards in the scientific community?

Researchers can advance AGL188W Antibody validation standards through these community-oriented approaches:

• Comprehensive Validation Reporting:

  • Document detailed validation protocols including all negative results

  • Share raw validation data through repositories like Antibodypedia

  • Report batch-to-batch variation observations

  • Publish application-specific optimization protocols

  • Contribute validation data to manufacturer databases

• Collaborative Validation Networks:

  • Establish multi-laboratory validation consortia

  • Implement standardized validation protocols across research sites

  • Share positive and negative control materials

  • Develop common reporting formats for validation outcomes

  • Create open-access validation datasets

• Advanced Validation Technologies:

  • Apply emerging techniques such as CRISPR-based antibody validation

  • Implement orthogonal validation with recombinant expression systems

  • Develop quantitative metrics for validation quality assessment

  • Integrate mass spectrometry verification of antibody targets

  • Establish minimum validation requirements for publication acceptance

• Educational Initiatives:

  • Develop training protocols for new researchers using AGL188W Antibody

  • Create troubleshooting decision trees for common problems

  • Establish best practice guidelines for application-specific protocols

  • Promote transparent reporting of antibody limitations

  • Advocate for complete methodological transparency in publications

These community-oriented approaches would elevate validation standards not only for AGL188W Antibody but potentially serve as a model for rigorous validation across research antibodies in fungal biology .